Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion
- Equal contributors
Arthritis Research & Therapy 2013, 15:R54 doi:10.1186/ar4216
This article is currently available as a provisional PDF. Reprints are produced from the final PDF, which is normally produced within 3 weeks.
Please complete the following form to register your interest in ordering reprints of this article. BioMed Central will contact you by email when the final PDF is available with details of how to obtain a quotation and place an order.
Fields marked * are required